Xponance’s Vera Therapeutics VERA Stock Holding History

Xponance’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229K	Buy	5,689 +1,330	+31%	+$57.3K	﹤0.01%	1413
2025 Q4	$221K	Buy	+4,359	New	+$155K	﹤0.01%	1342

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Xponance's VERA Position: Q1 2026 in Review

Xponance increased its Vera Therapeutics (VERA) stake by 31% in Q1 2026, buying an estimated $57.3K and bringing the position to 5,689 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Xponance first reported a position in VERA in Q4 2025 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

Xponance held 5,689 shares of Vera Therapeutics worth $229K as of Q1 2026.
Xponance bought 1,330 Vera Therapeutics shares in Q1 2026, an estimated $57.3K.
Vera Therapeutics made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1413 holding.
Xponance first reported a position in Vera Therapeutics in Q4 2025 and has held it in 2 quarters since.
229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.